+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Chemistry Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 188 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934344
The global Clinical Chemistry Market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 6% during the forecast period between 2024 and 2031. In 2024, the market size stands at an estimated US$10 billion, and it is expected to soar to US$15 billion by 2031. Key factors driving this expansion include the increasing elderly population and a surge in the incidence of chronic disorders, along with the growing adoption of Point of Care Testing Kits (POCT) and fully-automated clinical chemistry systems.

Growth Drivers for Clinical Chemistry Market

  • Increasing Elderly Population and Rise in Chronic Disorders: The global demographic landscape is witnessing a significant increase in the elderly population, which has brought about a higher prevalence of age-related disorders such as hypertension, diabetes, cardiovascular issues, liver, and kidney problems. The demand for diagnostic and treatment tests is consequently on the rise, boosted by preventive care initiatives, which are expected to drive the clinical chemistry market's growth during the forecast period.
  • Adoption of Point of Care Testing Kits (POCT) and Analyzers: Point-of-care testing has emerged as a crucial tool for the early detection, diagnosis, and monitoring of various diseases. The growing adoption of POCT kits and analyzers is a major catalyst in the Clinical Chemistry Market's growth. These technologies empower healthcare providers to diagnose illnesses more efficiently and at an earlier stage.
  • Fully-Automated Clinical Chemistry Systems: Healthcare institutions worldwide are increasingly acquiring fully-automated clinical chemistry systems equipped with built-in quality-assurance capabilities. These systems can process multiple samples simultaneously and perform tasks such as tube sampling, cap piercing, and dilution, enhancing the overall efficiency of healthcare diagnostic facilities. The rising adoption of these systems is set to drive the Clinical Chemistry Market's expansion throughout the forecast period.

Restraints in the Clinical Chemistry Market

High Capital Investments and Lack of Skilled Professionals: One of the primary constraints on the global clinical chemistry market is the substantial capital investment required to acquire clinical chemistry analyzers. Smaller laboratories and independent practitioners often struggle to afford these analyzers due to their high cost. Additionally, a shortage of skilled professionals, including lab technicians and pathologists, both in developed and emerging nations, poses a significant challenge to market growth.

Impact of Covid-19 Pandemic

Decrease in Revenue Due to Drop in Testing Frequency: The COVID-19 pandemic had a notable impact on the Clinical Chemistry Market, with lockdowns leading to a decrease in the frequency of medical testing as patients rescheduled their visits. However, with the relaxation of restrictions in 2021, testing rates are gradually returning to normal. Furthermore, the pandemic has stimulated demand for more precise and accessible testing kits, with major market players developing quick COVID-19 tests to offset the pandemic's impact.

Competitive Analysis

The global clinical chemistry market features a limited number of key players who are strategically focusing on growth through mergers and acquisitions to remain competitive in the industry. These companies are making informed decisions regarding both organic and inorganic expansion to broaden their product portfolios and increase market share.

Key Companies Profiled

  • Danaher Corporation
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Cardinal Health, Inc.
  • Mindray Medical International Limited
  • Hitachi, Ltd.
  • Hologic Inc.
  • Others

Clinical Chemistry Market Segmentation

Clinical Chemistry Market by Product Type

  • Clinical Chemistry Analysers
  • Poc Test Kits
  • Clinical Chemistry Reagents

Clinical Chemistry Market by End User

  • Hospital
  • Pathology Laboratories
  • Clinics
  • Outpatient Centres
  • Maternity Centres

Clinical Chemistry Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Clinical Chemistry Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Clinical Chemistry Market Outlook, 2018 - 2031
3.1. Global Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Clinical Chemistry Analysers
3.1.1.2. Poc Test Kits
3.1.1.3. Clinical Chemistry Reagents
3.2. Global Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospital
3.2.1.2. Pathology Laboratories
3.2.1.3. Clinics
3.2.1.4. Outpatient Centres
3.2.1.5. Maternity Centres
3.3. Global Clinical Chemistry Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Clinical Chemistry Market Outlook, 2018 - 2031
4.1. North America Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Clinical Chemistry Analysers
4.1.1.2. Poc Test Kits
4.1.1.3. Clinical Chemistry Reagents
4.2. North America Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospital
4.2.1.2. Pathology Laboratories
4.2.1.3. Clinics
4.2.1.4. Outpatient Centres
4.2.1.5. Maternity Centres
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Clinical Chemistry Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Clinical Chemistry Market Outlook, 2018 - 2031
5.1. Europe Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Clinical Chemistry Analysers
5.1.1.2. Poc Test Kits
5.1.1.3. Clinical Chemistry Reagents
5.2. Europe Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospital
5.2.1.2. Pathology Laboratories
5.2.1.3. Clinics
5.2.1.4. Outpatient Centres
5.2.1.5. Maternity Centres
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Clinical Chemistry Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Clinical Chemistry Market Outlook, 2018 - 2031
6.1. Asia Pacific Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Clinical Chemistry Analysers
6.1.1.2. Poc Test Kits
6.1.1.3. Clinical Chemistry Reagents
6.2. Asia Pacific Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospital
6.2.1.2. Pathology Laboratories
6.2.1.3. Clinics
6.2.1.4. Outpatient Centres
6.2.1.5. Maternity Centres
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Clinical Chemistry Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Clinical Chemistry Market Outlook, 2018 - 2031
7.1. Latin America Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Clinical Chemistry Analysers
7.1.1.2. Poc Test Kits
7.1.1.3. Clinical Chemistry Reagents
7.2. Latin America Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospital
7.2.1.2. Pathology Laboratories
7.2.1.3. Clinics
7.2.1.4. Outpatient Centres
7.2.1.5. Maternity Centres
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Clinical Chemistry Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Clinical Chemistry Market Outlook, 2018 - 2031
8.1. Middle East & Africa Clinical Chemistry Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Clinical Chemistry Analysers
8.1.1.2. Poc Test Kits
8.1.1.3. Clinical Chemistry Reagents
8.2. Middle East & Africa Clinical Chemistry Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospital
8.2.1.2. Pathology Laboratories
8.2.1.3. Clinics
8.2.1.4. Outpatient Centres
8.2.1.5. Maternity Centres
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Clinical Chemistry Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Clinical Chemistry Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Clinical Chemistry Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product Type vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Danaher corporation
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Abbott
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. F.Hoffmann-La Roche Ltd
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Siemens AG
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Thermo Fisher Scientific Inc.
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. bioMérieux SA
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Bio-Rad Laboratories Inc.
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Cardinal Health, Inc.
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Mindray Medical International Limited
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Hitachi, Ltd.
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Hologic Inc.
9.4.11.1. Company Overview
9.4.11.2. Therapy Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Danaher corporation
  • Abbott
  • F.Hoffmann-La Roche Ltd
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Cardinal Health, Inc.
  • Mindray Medical International Limited
  • Hitachi, Ltd.
  • Hologic Inc.

Methodology

Loading
LOADING...